Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.46% inched 0.20% higher to $163.72 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.17% rising 0.21% to 35,677.02 and the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.84% falling 0.11% to 4,544.90. The stock's rise snapped a two-day losing streak. Johnson & Johnson closed $16.20 below its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.70% fell 2.27% to $384.08, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.74% fell 0.02% to $81.15, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.32% rose 0.70% to $43.16. Trading volume (4.3 M) remained 1.8 million below its 50-day average volume of 6.1 M.